Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?

Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?

Background: For acute myeloid leukemia (AML) patients, the role of bridging consolidation chemotherapy after achieving first complete remission (CR1) in the transplant setting is a frequently debated issue. The lack of data from Asian patients led us to conduct this study. Methods: We retrospectivel...

Full description

Bibliographic Details
Main Authors:	Ja Min Byun, Dong-Yeop Shin, Youngil Koh, Junshik Hong, Inho Kim, Sung-Soo Yoon, Ji Yun Lee, Soo-Mee Bang, Jeong-Ok Lee
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-04-01
Series:	Therapeutic Advances in Hematology
Online Access:	https://doi.org/10.1177/20406207211001135

Similar Items

CORRIGENDUM to “Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?”
Published: (2021-06-01)

Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM)
by: Hyunkyung Park, et al.
Published: (2020-07-01)

Comparison of the efficacy of chemotherapy and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first remission in adults
by: S. N. Bondarenko, et al.
Published: (2015-09-01)

The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis.
by: Ja Min Byun, et al.
Published: (2016-01-01)

Busulfan plus melphalan melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma
by: Songyi Park, et al.
Published: (2021-05-01)

Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms
by: Jinyong Kim, et al.
Published: (2021-09-01)

Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy
by: Zeynep Arzu Yegin, et al.
Published: (2020-12-01)

Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
by: Hyunkyung Park, et al.
Published: (2019-04-01)

Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
by: Ahreum Lee, et al.
Published: (2020-04-01)

Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission
by: Nadjanara Dorna Bueno, et al.
Published: (2011-06-01)

Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype.
by: Sang-A Kim, et al.
Published: (2018-01-01)

Autologous hematopoietic stem cell transplantation in remission consolidation of acute myeloid leukemia with initially unfavorable prognostic factors
by: G. D. Petrova, et al.
Published: (2016-03-01)

Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation
by: Okamura Hiroshi, et al.
Published: (2011-04-01)

Allogeneic hematopoietic stem cell transplantation for acute myeloblastic leukemia in first remission
by: S N Bondarenko, et al.
Published: (2013-07-01)

Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia
by: Heejoo Han, et al.
Published: (2021-03-01)

Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia
by: Jodi J. Lipof, et al.
Published: (2018-06-01)

First Complete Remission versus other- than- First Complete Remission in Acute Myelogenous Leukemia with Allogeneic Hematopoietic Stem Cell Transplantation
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-04-01)

First Complete Remission versus other- than- First Complete Remission in Acute Myelogenous Leukemia with Allogeneic Hematopoietic Stem Cell Transplantation
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-06-01)

Efficacy of autologous versus allogeneic peripheral blood hematopoietic stem cell transplantation in non-high-risk acute myeloid leukemia patients in first complete remission
by: XIAO Han, et al.
Published: (2020-09-01)

Small RNA sequencing profiles of mir-181 and mir-221, the most relevant microRNAs in acute myeloid leukemia
by: Yun-Gyoo Lee, et al.
Published: (2019-01-01)

Metabolic Profiling during Acute Myeloid Leukemia Progression Using Paired Clinical Bone Marrow Serum Samples
by: Hyun Kyu Kim, et al.
Published: (2021-08-01)

Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation
by: Maud D'Aveni, et al.
Published: (2020-05-01)

Total Body Irradiation without Chemotherapy as Conditioning for an Allogeneic Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia
by: Sultan Altouri, et al.
Published: (2016-01-01)

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies.
by: Dandan Li, et al.
Published: (2015-01-01)

Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
by: Li Xuan, et al.
Published: (2021-01-01)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias with Hyperdiploid Karyotype
by: TL Gindina, et al.
Published: (2016-10-01)

Cardiac Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
by: María Facenda-Lorenzo, et al.
Published: (2016-01-01)

Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
by: Kunadt D, et al.
Published: (2021-09-01)

Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment
by: Guan-hua Hu, et al.
Published: (2020-06-01)

Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission
by: Rada M. Grubovikj, et al.
Published: (2012-06-01)

Outcome of allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission: a single institution study
by: Eun-Jung Lee, et al.
Published: (2012-03-01)

Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
by: June Young Chun, et al.
Published: (2021-01-01)

Strong association between herpes simplex virus-1 and chemotherapy-induced oral mucositis in patients with hematologic malignancies
by: Junshik Hong, et al.
Published: (2020-09-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES.
by: Gabriele Magliano, et al.
Published: (2020-10-01)

A Survey of Infection in Allogenic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
by: S R Safayi, et al.
Published: (2018-08-01)

Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation
by: Richard J. Lin, et al.
Published: (2013-01-01)

Myeloid Sarcoma after Allogenic Stem Cell Transplantation for Acute Myeloid Leukemia: Successful Consolidation Treatment Approaches in Two Patients
by: Silje Johansen, et al.
Published: (2018-01-01)

THE EFFICACY OF HIGH-DOSE CONSOLIDATION AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN FIRST REMISSION OF ACUTE MYELOID LEUKEMIA
by: I. A. Samorodova, et al.
Published: (2018-05-01)

Chronic Myeloid Leukemia: Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Tyrosine Kinase Inhibitors
by: EV Morozova, et al.
Published: (2019-03-01)

Pharmacologic Therapies to Prevent Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
by: Ahmad I. Antar, et al.
Published: (2020-11-01)